UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study
Bluebird Bio and Celgene posted phase 1 results of investigational drug bb2...
by Marian Chu
|
2017-12-13 14:30
라인
AstraZeneca to test Imfinzi on lung cancer patients
AstraZeneca is to conduct a clinical trial on anti-cancer immunotherapy Imf...
by Lee Hye-seon
|
2017-12-13 14:20
라인
Wholesalers sweat over drug companies’ forceful sales
Local wholesalers of pharmaceutical products are experiencing distress at t...
by So Jae-hyeon
|
2017-12-13 11:33
라인
Hanmi leads erectile dysfunction drug sales
Teva Pharmaceutical and Pfizer said Monday they will launch generic version...
by Marian Chu
|
2017-12-12 17:49
라인
Drugmakers lead job growth in manufacturing sector
The pharmaceutical industry has led the growth of jobs in the manufacturing...
by So Jae-hyeon
|
2017-12-12 15:12
라인
Korea approves Olumiant pills for treatment of rheumatoid arthritis
The government has approved Olumiant (ingredient: baricitinib), an oral med...
by Lee Hye-seon
|
2017-12-12 11:50
라인
Huons wins patent for oral medication of clarithromycin
Huons, a subsidiary of Huons Global, said Tuesday that it has acquired a pa...
by Lee Han-soo
|
2017-12-12 11:41
라인
JW Pharma unveils trial result for target anticancer treatment
JW Pharmaceuticals said Monday that it has presented phase 1a/1b clinical t...
by Lee Han-soo
|
2017-12-11 16:55
라인
Pfizer pays most to doctors for overseas academic events
Among multinational pharmaceutical companies, Pfizer Korea paid the largest...
by So Jae-hyeon
|
2017-12-11 16:28
라인
JW CreaGene starts clinical trial for glioblastoma treatment
JW CreaGene, a subsidiary of JW Shinyak, said Thursday that it has started ...
by Lee Han-soo
|
2017-12-07 15:19
라인
Local novel drugs achieve rapid growth in Q3
Novel drugs by local drugmakers achieved a rapid sales growth in the third ...
by So Jae-hyeon
|
2017-12-07 11:53
라인
Vetter wins Corporate Health Award
Global contract development and manufacturing organization Vetter Pharma ha...
by Marian Chu
|
2017-12-07 10:55
라인
Humedix opens 2nd factory in Jecheon
Huons Global Vice Chairman Yoon Sung-tae (center) and other executives and ...
by Lee Han-soo
|
2017-12-06 16:49
라인
Novartis Korea faces tax investigation
The National Tax Service launched a tax investigation into Novartis Korea o...
by Nam Doo-hyun
|
2017-12-06 10:55
라인
Pfizer Korea wins pneumonia vaccine patent dispute with SK Chemicals
The Patent Court of Korea Wednesday decided to uphold Pfizer Korea’s patent...
by Marian Chu
|
2017-12-05 18:16
라인
Daewoong denies defeat in suit against Korea United
Daewoong Pharmaceutical said Tuesday that the recent dismissal of the paten...
by Lee Han-soo
|
2017-12-05 16:13
라인
Industry groups to support AI-based new drugs
The Korea Pharmaceutical and Bio-pharma Manufacturers’ Association (KPBMA) ...
by So Jae-hyeon
|
2017-12-05 16:13
라인
Multinational drugmakers sweep local sales in Q3
Multinational pharmaceutical companies have swept the local sales in the th...
by So Jae-hyeon
|
2017-12-04 16:08
라인
SNUBH first to prove non-invasive test works for glaucoma patients
Researchers at Seoul National University Bundang Hospital (SNUBH) have prov...
by Marian Chu
|
2017-12-04 14:58
라인
Pfizer taps Kim Sun-a to lead Essential Health division in Japan
Pfizer has elected Kim Sun-A to head Pfizer’s Essential Health division in ...
by Marian Chu
|
2017-12-04 12:14
-
이전
101
102
103
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top